The role of PCS in primary biliary cholangitis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000040564

Enrollment

Unknown

Registered

2020-12-02

Start date

2020-12-01

Completion date

Unknown

Last updated

2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary biliary cholangitis

Interventions

PBC:none

normal control group:none

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Elevated biochemical indicators reflecting cholestasis; (2) serum AMA-M2 antibody positive or Anti-mitochondrial (AMA) antibody positive; (3) Pathological examination of liver biopsy meets the characteristics of PBC.

Exclusion criteria

Exclusion criteria: With other autoimmune diseases

Design outcomes

Primary

Measure	Time frame
P-cresol sulfate;	—

Countries

China

Contacts

Public ContactTang Ying-mei

The Second Affiliated Hospital of Kunming Medical University

tangyingmei_med@163.com+86 15308845032

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026